Thanks Bruce for relaying this to us. It sounds as if they've completed "Phase I" of the IRB study and are in the process of completing "Phase II" of the same study. Mr. Dagan seemed to say he expects to be able to relay progress shortly... but it also appears as though the study will not be complete until Q3. I'm OK with this so long as the company communicates with the shareholders the reasons for the delay (if it can be called that) and gives us some sort of timeline as to when we can expect completion. It's amazing how long these studies can take. I also agree that for future studies timelines should be negotiated beforehand. Thanks again for your efforts. This should give all investors confidence in the company, in our products, and in the process.